Review of Ruxolitinib for Treatment of Non-Segmental Vitiligo. | Ann Pharmacother;57(8): 948-955, 2023 Aug. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Review of Ruxolitinib for Treatment of Non-Segmental Vitiligo.

Hwang, Jacqueline R; Driscoll, Marcia S.

Affiliation

Hwang JR; Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA.
Driscoll MS; Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA.

Ann Pharmacother ; 57(8): 948-955, 2023 Aug.

Article in En | MEDLINE | ID: mdl-36564903

Subject(s)
Key words

clinical pharmacology; dermatology; ruxolitinib; vitiligo

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo / Drug-Related Side Effects and Adverse Reactions Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vitiligo / Drug-Related Side Effects and Adverse Reactions Limits: Humans Language: En Journal: Ann Pharmacother Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Document type: Article Affiliation country: Country of publication: